• Hypoxia induces altered platelet proteome/reactivity which correlates with a prothrombotic phenotype.
Introduction
Hypoxia, experienced either during physical activities such as ascent to mountains, air travel, sports activities or with pathological conditions like solid tumors has been suggested to be associated with thrombotic episodes. [1] [2] [3] [4] [5] In the case of high altitude hypoxic exposure, both venous as well as arterial thrombotic events can occur, which include pulmonary thromboembolism, cerebral venous thrombosis, portal vein thrombosis, aortic thrombosis, stroke, and transient ischemic attack. [6] [7] [8] [9] At extreme altitude, adverse environmental conditions including hypobaric hypoxia and cold may facilitate the development of the corresponding prothrombotic phenotype.
In the past, various studies have been reported with the focus on hematological factors, and proteins involved in thrombin generation and fibrinolysis to understand the altitude-induced thrombotic events. [10] [11] [12] [13] Although platelets play an indispensable role in thrombogenesis, the involvement of platelets in hypoxia induced thrombotic events has not been adequately explored.
Most of the studies were focused on changes in platelet numbers with only a few reports on platelet reactivity at high altitude. [14] [15] [16] [17] In fact, in chronic obstructive pulmonary disease and sleep apnea, hypoxia has been associated with increased platelet reactivity. 18, 19 Platelet hyperreactivity reflected by enhanced platelet adhesion, activation and aggregation, is a sum of finely coordinated cell signaling events involving a shift in platelet proteome/secretome and structural proteins. In conjunction with this, the tightly controlled cytosolic Ca 2+ also act as an important secondary messenger to regulate the fundamental platelet reactivity via the key downstream signaling cascades. 20 The proteome analysis, which is utilized for identifying novel proteins and pathways, has become an ideal tool to study anucleated cells like platelets. Previously, proteomic analysis For personal use only. on November 1, 2017. by guest www.bloodjournal.org From revealed differential regulation of proteins in diseases like acute coronary syndrome. 21, 22 The cellular functions in platelets are regulated primarily by changes in protein expression and their modifications. In the present study, exposure of Sprague Dawley rats to acute high altitude hypoxia resulted in platelet hyperreactivity leading to a prothrombotic phenotype. The proteome analysis of these phenotypically altered platelets revealed differential expression of proteins, which are involved in coagulation, calcium homeostasis, signal transduction, acute phase response, and cytoskeletal reorganization. The disturbed calcium homeostasis was further explored by addressing cytosolic Ca 2+ levels and calpain activity in platelets of hypoxic animals.
Calpain small 28 kDa subunit-1(CAPNS1), which functions like chaperone for calpain proteases 23 and controls cell spreading and migration, 24 was found to be upregulated in hypoxia exposed animals. Taking into consideration that calpains are activated by elevated cytosolic Ca 2+ and are involved in platelet reactivity 25, 26 , the prothrombotic role for calpain under hypoxia was further confirmed by in vivo model of hypoxia-induced thrombosis. To investigate the potential of these pre-clinical investigations for clinical relevance, the calpain activity and sP-selectin level were analyzed in plasma samples of patients who developed deep vein thrombosis (DVT) at high altitudes (>3648 m). The results from these studies for the first time suggest that hypoxic environment alters the platelet proteome and induces platelet hyperreactivity leading to a prothrombotic phenotype which is mainly mediated by activation of calpain.
Materials and Methods

Materials
Alpha-thrombin, adenosine diphosphate (ADP) and chronolume luciferin-luciferase reagents were purchased from Chrono-log (Havertown, PA). Anti-CD41 and anti-αIIbβ 3 antibodies were 
Animal exposure to simulated high altitude (HA) conditions
All experiments were conducted in accordance with Committee for the Purpose of Control and Supervision of Experiments on Animals, Government of India. Male Sprague Dawley rats, weighing 150-250g were kept under standard laboratory conditions. The animals were exposed to simulated HA (hypobaric hypoxia) conditions in a specially designed animal decompression chamber, which was maintained at pressure of 282 torr (equivalent to an altitude of 7620 m with 8% oxygen) and at 10°C for various durations. Animals were exposed to simulated hypobaric hypoxia with cold surrounding since at high altitude regions the associated low temperatures may also affect the biological systems. Following optimization of the temperature range, 10°C was selected as a suitable temperature and was used for further hypoxic exposure studies. Based on initial hematological and coagulation screening data and previous studies, platelet reactivity studies were conducted after 6h exposure to simulated altitude.
Flow restriction animal model
To model the localized hypoxia induced thrombosis, thrombus was induced in rats by proximal ligation of the inferior vena cava (IVC) just below the renal veins and ligation of lateral tributaries as previously described 27 with some modifications (see supplementary methods for details). 
Statistical Analysis
Values are expressed as mean ± standard error in mean (SEM). The statistical significance between two groups was tested by nonparametric unpaired two tailed t test using Prism5 software (Graphpad) and for multiple group comparison one way ANOVA was applied followed by Dunnett's test. A p value less than .05 was considered as significant.
Results
Hypoxic exposure results in hypercoagulative state
In order to investigate whether hypoxic exposure results in prothrombotic phenotype in rats, bleeding time (by tail immersion and filter paper methods) and coagulation assays (PT, aPTT) were performed after hypoxic exposure. A significant shortening of bleeding times (202 ± 29)
For personal use only. on November 1, 2017. by guest www.bloodjournal.org From was observed in exposed animals as compared to controls (440 ± 54; P < .05, n = 10) ( Figure   1A ). The visual inspection of filter paper indicates the thickening of blood in exposed animals ( Figure 1B) . Similarly, coagulation assays demonstrated a hypercoagulative state under hypoxic environment as reflected by a significantly decreased PT value and a similar trend in aPTT ( Figure 1C -D). No significant change was observed in hemoglobin, hematocrit levels or platelet count in hypoxia exposed animals except for decrease in WBC count ( Supplementary Table S1 ).
As hypoxia exposure to rats also involved cold surroundings (chamber temperature of 10°C), bleeding time assay was also performed in rats exposed to hypoxia under normothermic surrounding (chamber temperature of 28°C) to ascertain the possible role (if any) of moderate cold surrounding on hypercoagulative tendency. The exposure under normothermic conditions resulted in significant reduction in bleeding time as under hypothermic conditions (Supplementary Figure S1A ). Collectively, these results support the view that altitude hypoxic conditions induce a prothrombotic phenotype.
Exposure to hypoxia induces platelet hyperreactivity
The effect of hypoxic exposure on platelets' tendency for adhering to extracellular matrix proteins was investigated in vitro by platelet adhesion assay. Platelets isolated from exposed animals demonstrated an enhanced adhesion to both collagen and fibrinogen coated surfaces.
The average size of adhered platelets and percent area covered by the same were significantly higher in exposed group as compared to controls (Figure 2A -F); the increase was greater on collagen surface. Next, we tested whether platelet aggregation and dense granule release was affected with hypoxic exposure. Platelets from exposed animals showed significantly increased aggregation in response to ADP in a dose dependent manner ( Figure 2G -H). Both rate and extent For personal use only. on November 1, 2017. by guest www.bloodjournal.org From of platelet aggregation were higher in exposed group in response to ADP (2.5 and 5µM; P< .05) whereas only modest difference was observed with thrombin (data not shown). The dense granule release, as evaluated by luminescence based ATP release, was also found to be significantly higher (P< .05) in platelets from exposed animals compared to that of controls ( Figure 2I -J). Activated platelets bear increased numbers of various transmembrane proteins which serve as platelet activation markers. A flowcytometry based approach was used for analyzing the surface expression of CD41 and α IIbβ 3 . The anti-αIIbβ 3 antibody that interacts with α IIbβ 3 receptor complex 28 demonstrated an enhanced surface expression of this complex which reflects greater platelet activation upon induction with ADP in exposed animals than that in controls ( Figure 3A ,C). CD41, another platelet activation marker also exhibited a similar response ( Figure 3B ,D). Since platelet aggregation requires the binding of fibrinogen to its receptor α IIbβ 3 on the platelet surface, 29 we further evaluated platelet-fibrinogen interactions using an in vitro clot retraction assay. As shown in Figure 3E and F, hypoxic exposure resulted in higher reduction in clot size or increased the clot retraction. The clot retraction in exposed groups were 30% and 20% more than that of control groups at 30 minutes and 60 minutes respectively. These observations reflected higher platelet reactivity and greater plateletfibrinogen interactions in exposed animals which corroborate with the other platelet assays like aggregation, activation and adhesion.
Platelet function was also tested in rats exposed to hypoxia under normothermic surrounding 
Hypoxic exposure modulates platelet proteome
To obtain an insight into the molecular events underlying platelet hyperreactivity in response to hypoxic exposure, the platelet proteome was analyzed using two dimensional gel electrophoresis followed by identification of differentially expressed proteins by MALDI TOF MS/MS ( Figure   4A -C). Initial optimizations suggested that the pH range of 4-7 was ideal for 2D-PAGE on platelet samples as this range provided the detection of maximum number of protein features and improved resolution as compared to other narrow pI ranges. Software analysis of gel images resulted in detection of over 700 spots per gel, from which 258 spots were chosen for differential expression analysis. The MS/MS data analysis resulted in identification of 27 differentially expressed proteins in platelet samples obtained from exposed animals. From 27 identified proteins, 21 proteins had Mascot™Mowse score equal to or greater than 50 (Table 1) and 19 were up-regulated while 8 proteins were suppressed. Bioinformatic analysis of identified differentially expressed proteins revealed that all these proteins belong to different cellular locations like cell membrane, cytoskeletal, mitochondrial, endoplasmic reticulum, vesicular etc.
( Figure 4D ) and were found to be involved in various important biological processes including acute phase response, blood coagulation and complement activation, oxidative stress response, platelet activation, lipoprotein metabolism, lipid transport, vasodilation etc. (Table 1) .
Furthermore, these proteins correspond to diverse molecular functions including nucleotide binding, hormone binding, calcium channel regulation, ATPase activity, calcium binding, enzyme inhibition and response to ions like Fe 3+ , Mg 2+ , Ca 2+ etc. ( Figure 4E ). Based on cutoff score, fold induction and functional priorities, a protein list was prepared for analysis, validation and follow up experiments. To validate proteomic results, the levels of selective proteins which included fibrinogen gamma, calreticulin, calumenin, CAPNS1, non-neural alpha enolase, Janus kinase 3 and rho guanine exchange factor-7 (ARHGEF7) were quantitated by rat specific ELISA kits ( Figure 5A-B ). The platelet specific protein-protein interaction analysis using web tool 'PlateletWeb'
(http://plateletweb.bioapps.biozentrum.uni-wuerzburg.de) suggested the involvement of these proteins in key regulatory events ( Figure 5C ). However, ELISA results for three of the proteins including fibrinogen beta, fibrinogen alpha and coronin 1A were not in accordance with the proteomic findings and thus not followed further (data not shown). Proteins with prothrombotic nature which includes important coagulation factors, tissue factor and fibrinogen were upregulated, while those having antithrombotic activity, including calcium binding proteins calreticulin and calumenin 30,31 were suppressed under hypoxic conditions. The identified proteins also included some upregulated proteins playing major roles in platelet activation process. A recent study had observed TF expression in human platelets but not in platelets from mice. 32 Also, there is conflicting information regarding tissue factor (TF) expression in platelets, thus we have examined the TF mRNA to verify its expression in platelets from control and hypoxia exposed animals using RT-PCR (Supplementary Figure S2 ). The RT-PCR data demonstrated the presence of TF transcripts in platelets and TF expression was found to be enhanced in hypoxia exposed rats. These results strongly supported proteomic and ELISA data and suggest that differential TF expression regulation in rat platelets may probably be due to signal dependent splicing as demonstrated in human platelets earlier. 33 Taken together, the hypoxia induced changes in the expression pattern of platelet proteins indicate that hypoxic exposure shifts the platelet proteome towards prothrombotic state.
Calpains play a vital role in hypoxia induced prothrombotic phenotype
Analysis of hypoxia induced differentially expressed proteins directed our focus towards calcium triggered events. Calcium based regulation of intracellular events are known to be central in platelet activation. Calpain, a thiol protease, has been found to be regulated by calcium influx and oxidative stress. 34, 35 Upregulation of CAPNS1 in platelets from exposed animals was evident from proteomic and ELISA results (Figures 4-5 ). To confirm the activation of platelet calpain, platelet intracellular calcium and calpain activity were measured in PRP, which were found to be significantly higher in exposed animals as compared to controls ( Figure 6A Figure 6C ). Further, the preinfusion of animals with PD150606 (1mg/kg body weight) via tail vein prior to hypoxic exposure resulted in partial reversal of hypoxia induced platelet hyperreactivity ( Figure 6D ) and partial restoration of reduced bleeding time in exposed animals (360 ± 45 with PD150606, vs 212 ± 22 with vehicle). These in vitro and in vivo observations indicated that CAPNS1 regulated calpain might be playing an important role during hypoxia induced thrombogenesis. To further investigate the role of CAPNS1 dependent calpain regulation in hypoxia induced thrombosis in vivo, a flow restriction animal model was used that result in generation of thrombus due to ligation ( Figure 6E ). In this model the thrombus
For personal use only. on November 1, 2017. by guest www.bloodjournal.org From formation was induced by stasis of blood flow at the site of ligation which creates a hypoxic microenvironment. 27,37 Animals pre-infused with calpain inhibitor, PD150606 (1mg/kg body weight) demonstrated significantly reduced thrombus size (0.80 ± 0.33) as compared to those preinfused with vehicle (3.41 ± 0.51, P< .01) ( Figure 6E-F) . Similarly, calpain activity and platelet aggregation were found to be significantly lower in animals pre-infused with PD150606 as compared to vehicle controls ( Figure 6G -H). The histological investigations also suggested the reduction in thrombus formation ( Figure 6I ). Moreover, to demonstrate the direct effect of hypoxia on thrombus formation, the IVC ligated animals were exposed to simulated environmental hypoxia (using decompression chamber). The thrombus formation was found to be accelerated after 6h of hypoxic exposure, reflected by significantly enhanced thrombus size in these animals as compared to unexposed ligated animals (Supplementary Figure S3 ).
Furthermore, the effect of preinfusion with PD150606 was more pronounced as indicated by thrombus size in exposed ligated animals as compared to their unexposed counterparts (Supplementary Figure S3 ). To exclude the off-target effect of a single calpain inhibitor (PD150606), two additional known peptidyl cell permeable inhibitors (calpeptin and MDL28170) of calpain activity were also tested. The preinfusion of animals with these inhibitors individually resulted in significant attenuation in thrombus size (Supplementary Figure S4) .
However, the PD150606 proved to be the most potent among these three inhibitors used.
Next, for translational implications, we conducted a human study to investigate the calpain activity in patients who had developed DVT at high altitude. Consistent with in vivo animal studies, the calpain activity was found to be significantly higher in human patients' plasma samples as compared to the controls (1.213± 0.121 vs. 0.70 ± 0.062, P = .0014, n = 10) ( Figure   6K ). All ten patients selected for this study were negative for two common thrombophilia traits Moreover, we did not find any association between thrombophilia factors and enhanced calpain activity in these patients (see Supplementary Table S2 for details). There was no significant difference in the mean age (35yr) of patients and controls (32 yr) and were healthy with normal range of BMI (<29.9 kg/m 2 ). We also analyzed the levels of soluble P-selectin (sP-selectin), a soluble marker of platelet activation in the plasma samples of patients and control subjects.
Plasma sP-selectin was significantly higher in patients as compared to control subjects suggestive of increased platelet activation in patients ( Figure 6J ). These results emphasize the translational implication of pre-clinical data and strongly support a prothrombotic role for calpain under hypoxic conditions.
Discussion
This study is the first attempt to analyze the platelet proteome under hypoxic conditions as well as to demonstrate the hypoxia induced differential expression of platelet proteins. We found that the enhanced calpain activity regulated by CAPNS1 plays a major role in platelet hyperreactivity and thrombogenesis under hypoxic environment. Although in many studies hypoxia associated with high altitude has been suggested to be prothrombotic [10] [11] [12] , certain studies have challenged these observations. 38, 39 Hence, in the present study we tried to investigate and understand the effect of acute hypoxic exposure on coagulation and platelet reactivity.
We observed the prothrombotic phenotype in rats after hypoxia exposure, which was reflected by decreased bleeding and prothrombin times. The platelets from these experimental hypoxic rats showed higher reactivity, which was demonstrated by measuring multiple parameters including platelet adhesion, aggregation and activation. The hyperreactivity of platelets was further supported by the enhanced surface expression of CD41 and α IIbβ 3 , and increased clot retraction in exposed animals. Earlier studies on platelet reactivity under hypoxic environment had produced conflicting results. 16, 39 Rats were selected as the ideal animal model to perform this study because of two factors. First, rats are preferred over mice to conduct pathophysiological studies and secondly, there has been significant similarities in rat and human platelet proteins which encourages the use of rat models to study platelets and related prothrombotic events. 40 The current animal model involves hypobaric hypoxic exposure at surrounding temperature of 10°C to reproduce the hypoxic conditions at high altitude regions which have much lower temperatures than sea level regions. To evaluate the effect of cold surrounding upon hypoxia induced prothrombotic tendency, animals were exposed to hypoxia under both normothermic (chamber temperature of 28°C) and hypothermic (chamber temperature of 10°C) conditions and bleeding time as well as platelet aggregation assays were performed. The results were similar in both the groups i.e. significantly decreased bleeding time and increased platelet aggregation as compared to control (Supplementary Figure S1 ). These preliminary observations emphasize that hypoxia is the key factor affecting platelets at high altitude.
Until 1990s, it was believed that platelets carry proteins synthesized from their parent cell megakaryocytes. But with the evidences of de novo protein synthesis and discovery of protein synthesis machinery in platelets, they were found to be active protein synthesizing anucleated cells. The subsequent discovery of platelet spliceosome and alternative splicing revealed a post transcriptional mode of regulation of protein expression in platelets making the platelet biology more complex. Therefore, we analysed the platelet proteome to study the effect of hypoxic exposure on platelet proteins and thus made an attempt to understand the events underlying hypoxia induced platelet hyperreactivity. The proteomic analysis of hypoxic platelets exhibited differential expression of many platelet proteins. These observations were comprised of For personal use only. on November 1, 2017. by guest www.bloodjournal.org From important coagulation cascade proteins like fibrinogen and tissue factor, some key signalling proteins involved in calcium regulation and platelet activation, and CAPNS1, which is responsible for regulating calpain activity. The bioinformatic analysis of the data revealed that the altered proteins belonged to different cell locations with diverse molecular functions, therefore suggestive of the whole platelet proteome alteration in the hypoxic environment. The increased levels of platelet tissue factor in hypoxia supports our coagulation assay data where PT was found to be decreased after hypoxia. Hypoxia not only resulted in up-regulation of prothrombotic proteins, but also conferred a decreased antithrombotic tendency by suppressing endoplasmic reticulum resident proteins calreticulin and calumenin, which have been reported to be antithrombotic in nature 30,31 and maintains calcium homeostasis. 20 The enhanced CAPNS1 regulated calpain activity along with elevated Ca 2+ may play an important role in hypoxia induced thrombogenesis as demonstrated by in vivo animal results. The in vivo hypoxic setting for thrombus formation was created by inferior vena cava ligation approach, that resulted in a hypoxic microenvironment due to stasis. 27, 37 The up-regulation of 'hypoxia inducible factor 1α' in both exposed (but non-ligated) and thrombotic animals strongly supported our approach (data not shown). The pre-treatment with a highly selective and potent calpain inhibitor PD150606 resulted in reversal of platelet hyperreactivity and reduced the thrombus formation in these animals. The effect of calpain inhibition on thrombus formation was also analyzed with two additional calpain inhibitors i.e. MDL28170 and calpeptin to rule out possible off target effects.
With the current observations presented in this manuscript, few points about probable mode(s) of action of calpain can be drawn. Firstly, the increased proteolytic activity of calpain in platelets, which was observed without agonist induced aggregation ( Figure 6A ) demonstrates that the For personal use only. on November 1, 2017. by guest www.bloodjournal.org From calpain activation by hypoxia precedes agonist induced platelet aggregation. Secondly, platelet hyperreactivity induced by hypoxia depends largely on calpain activity as preinfusion of calpain inhibitor limits the hypoxia induced platelet aggregation ( Figure 6D ). Thirdly, calpain activity affects platelet hyperreactivity induced by hypoxia more than that of normoxic platelets ( Figure   6D ). It is known that calpain gets fully activated (and translocates to membrane) upon agonist induced platelet activation. 41 Therefore, from the current observations it appears that hypoxic exposure accelerates the rate of transformation of calpain from its resting state to fully activated state and positively regulates hypoxia induced platelet reactivity. However, it remains to be explored as to whether hypoxia alters the known calpain reactions in platelets or it triggers an altogether different set of biomolecular reactions. These nascent findings about platelet-calpain relationship under hypoxia may provide the course for future directions to decipher the exact mechanism by which calpain protease system mediate hypoxia induced prothrombotic effects via regulating platelet function as well as drive the hunt for novel substrates of calpain in platelets under hypoxic environment. Another interesting approach can be investigating the role of calpain in modulating platelet proteome under hypoxia citing recently reported stabilization of the platelet proteome of diabetic patients by calpain inhibition. 42 Besides platelet activation, the prothrombotic nature of calpain can also be attributed to the diverse nature of its substrates which comprise of cytoskeletal proteins, membrane proteins, kinases, phosphatases and ATPases. 43 More importantly, the human plasma samples of the rare type of lower limb DVT caused by hypoxic environment at high attitudes, also had elevated calpain activity and sP-selectin levels. The sample size in the study was limited due to certain constraints such as lower inhabitability and accessibility at extreme altitudes as well as
For personal use only. on November 1, 2017. by guest www.bloodjournal.org From complicated logistic issues. In spite of these constraints, the important findings in the present study are suggestive of its potential translational application.
In conclusion, this study for the first time reports that a hypoxic environment results in an altered platelet proteome inducing the platelet hyperreactivity. Further, CAPNS1 mediated regulation of calpain activity appears to play a major role in hypoxia induced thrombogenesis both in animals and humans proposing a potential link between oxygen compromised status and thrombogenic index. Hypoxia exposure results in hypercoagulation. Rats were exposed to simulated hypoxic conditions as described in methods; tail vein bleeding assay, PT and aPTT assays were performed. (A) Rat tail was transected 4 mm from the tip and immersed in warm normal saline (37°C) and the time taken for complete cessation of blood flow was noted (which was significantly lower in hypoxia exposed rats than in controls). (B) In the filter paper method, the tail tip was blotted gently onto Whatman paper at one min intervals. The diameter of blood spots and the duration of bleeding were significantly lower in exposed rats compared to control rats. (C and D) PT and aPTT were measured in citrated plasma and reflected a similar trend as bleeding time. Data are presented as mean ± SEM, (n=10). *P < .05 vs control. For personal use only. on November 1, 2017. by guest www.bloodjournal.org From Figure 4 . Platelet proteome analysis from control and exposed rats. Platelets were isolated from both control and hypoxia exposed animals, total platelet protein was prepared for platelet proteome analysis. Each protein lysate was subjected first to isoelectric focussing, followed by SDS-PAGE in second dimension as described in Methods. The differentially expressed proteins For personal use only. on November 1, 2017. by guest www.bloodjournal.org From
